ATYR · Company research
aTyr Pharma, Inc. Common Stock (ATYR): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| aTyr Pharma stock heads into November 5 earnings at USD 18.9 million value - ad-hoc-news.de | aTyr Pharma stock heads into November 5 earnings at USD 18.9 million value ad-hoc-news.de | View source ↗ | ad-hoc-news.de | Oct 15, 2026 | neutral | 0 | 0.6 |
| ATYR261016C00000500 Interactive Stock Chart | ATYR Oct 2026 0.500 call Stock - Yahoo Finance | ATYR261016C00000500 Interactive Stock Chart | ATYR Oct 2026 0.500 call Stock Yahoo Finance | View source ↗ | Yahoo Finance | Oct 15, 2026 | neutral | 0 | 0.6 |
| FEDERATED HERMES, INC. Trims aTyr Pharma Inc (ATYR) Stake -- Shares Trade 61% Below GF Value - GuruFocus | FEDERATED HERMES, INC. Trims aTyr Pharma Inc (ATYR) Stake -- Shares Trade 61% Below GF Value GuruFocus | View source ↗ | GuruFocus | Oct 14, 2026 | neutral | 0 | 0.6 |
| An experimental protein reduced lung fibrosis in a model. aTyr expects to move it into testing in 2027. - Stock Titan | An experimental protein reduced lung fibrosis in a model. aTyr expects to move it into testing in 2027. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| aTyr Pharma, Inc. (NASDAQ: ATYR) Share Price, ATYR Stock News, ATYR Share Price & Updates - Kalkine | aTyr Pharma, Inc. (NASDAQ: ATYR) Share Price, ATYR Stock News, ATYR Share Price & Updates Kalkine | View source ↗ | Kalkine | Oct 9, 2026 | neutral | 0 | 0.6 |
| ATYR Oct 2026 0.500 call (ATYR261016C00000500) interactive stock chart - Yahoo Finance UK | ATYR Oct 2026 0.500 call (ATYR261016C00000500) interactive stock chart Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 8, 2026 | neutral | 0 | 0.6 |
| ATYR Oct 2026 4.000 call (ATYR261016C00004000) stock historical prices and data - Yahoo Finance UK | ATYR Oct 2026 4.000 call (ATYR261016C00004000) stock historical prices and data Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 8, 2026 | neutral | 0 | 0.6 |
| A trust and three trustees report a passive stake above 5% in aTyr Pharma (ATYR). - Stock Titan | A trust and three trustees report a passive stake above 5% in aTyr Pharma (ATYR). Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| ATYR Oct 2026 4.000 call (ATYR261016C00004000) interactive stock chart - Yahoo Finance UK | ATYR Oct 2026 4.000 call (ATYR261016C00004000) interactive stock chart Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 5, 2026 | neutral | 0 | 0.6 |
| The CFO receives options on 410,000 shares with a $0.30 exercise price at aTyr Pharma (ATYR). - Stock Titan | The CFO receives options on 410,000 shares with a $0.30 exercise price at aTyr Pharma (ATYR). Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| Why is aTyr Pharma stock rallying today? - Investing.com | Why is aTyr Pharma stock rallying today? Investing.com | View source ↗ | Investing.com | Sep 24, 2026 | neutral | 0 | 0.6 |
| FDA and aTyr align on a planned lung disease drug trial for up to about 372 patients. - Stock Titan | FDA and aTyr align on a planned lung disease drug trial for up to about 372 patients. Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| aTyr Pharma FDA Alignment Sets Protocol for Phase 3 Efzofitimod Study in Pulmonary Sarcoidosis - Yahoo Finance | aTyr Pharma FDA Alignment Sets Protocol for Phase 3 Efzofitimod Study in Pulmonary Sarcoidosis Yahoo Finance | View source ↗ | Yahoo Finance | Sep 24, 2026 | neutral | 0 | 0.6 |
| aTyr Pharma Provides Update on FDA Response Timing for Planned Phase 3 Efzofitimod Sarcoidosis Study - Quiver Quantitative | aTyr Pharma Provides Update on FDA Response Timing for Planned Phase 3 Efzofitimod Sarcoidosis Study Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 1, 2026 | neutral | 0 | 0.6 |
| aTyr Pharma And 2 Other Penny Stocks With Promising Potential - Simply Wall Street | aTyr Pharma And 2 Other Penny Stocks With Promising Potential Simply Wall Street | View source ↗ | Simply Wall Street | Aug 26, 2026 | neutral | 0 | 0.6 |
| Here's Why We're A Bit Worried About aTyr Pharma's (NASDAQ:ATYR) Cash Burn Situation - Simply Wall Street | Here's Why We're A Bit Worried About aTyr Pharma's (NASDAQ:ATYR) Cash Burn Situation Simply Wall Street | View source ↗ | Simply Wall Street | Aug 14, 2026 | neutral | 0 | 0.6 |
| Why is aTyr Pharma stock gaining today? - Investing.com | Why is aTyr Pharma stock gaining today? Investing.com | View source ↗ | Investing.com | Aug 10, 2026 | neutral | 0 | 0.6 |
| aTyr Pharma cuts 60% of workforce after Q2 results - Quiver Quantitative | aTyr Pharma cuts 60% of workforce after Q2 results Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 7, 2026 | neutral | 0 | 0.6 |
| ATYR Forecast — Price Target — Prediction for 2027 - TradingView | ATYR Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Insider Buyers At aTyr Pharma Likely Disappointed With 19% Slide - Simply Wall Street | Insider Buyers At aTyr Pharma Likely Disappointed With 19% Slide Simply Wall Street | View source ↗ | Simply Wall Street | Jun 9, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.